{"filing":{"accession_number":"0001493152-26-036753","cik":"0000946644","ticker":"AIM","company_name":"AIM ImmunoTech Inc.","form":"8-K","filing_date":"2026-08-10","report_date":"2026-08-07","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315226036753/form8-k.htm"},"events":[{"id":26422,"run_id":24014,"accession_number":"0001493152-26-036753","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The 8-K discloses under Item 2.02 (Results of Operations and Financial Condition) a press release announcing AIM ImmunoTech's financial results for the quarter ended June 30, 2026. The press release reports Q2 2026 financial metrics including cash position ($9.9M vs $3.0M year-end 2025), R\u0026D expenses ($589K vs $1.2M prior year), G\u0026A expenses ($2.9M vs $1.5M prior year), and net loss of $(3.8M) or $(0.43) per share. This is a standard quarterly earnings disclosure material to investors assessing the company's financial condition and operational progress.","company_name":"AIM ImmunoTech Inc.","ticker":"AIM","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":27542,"accession_number":"0001493152-26-036753","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The 8-K discloses under Item 2.02 (Results of Operations and Financial Condition) a press release announcing AIM ImmunoTech's financial results for the quarter ended June 30, 2026. The press release reports Q2 2026 financial metrics including cash position ($9.9M vs $3.0M year-end 2025), R\u0026D expenses ($589K vs $1.2M prior year), G\u0026A expenses ($2.9M vs $1.5M prior year), and net loss of $(3.8M) or $(0.43) per share. This is a standard quarterly earnings disclosure material to investors assessing the company's financial condition and operational progress.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T12:41:44.727735+00:00","company_name":"AIM ImmunoTech Inc.","ticker":"AIM","filing_date":"2026-08-10"}]}